Waters Corporation’s combination with the Biosciences and Diagnostic Solutions businesses of BD is now complete.

4Q Earnings: $1.1 billion (earnings were $72 million 4Q24) FY Earnings: $7.1 billion (loss of $8.9 billion FY24) ...

Innovent Biologics and Eli Lilly and Company are starting a new collaboration to advance novel medicines in immunology and ...

PharmaEssentia Corporation will invest approximately $46 million to establish a new, wholly owned manufacturing subsidiary in ...

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

Eurofins Viracor BioPharma Services is expanding its service portfolio with enhanced bioanalytical testing capabilities fully ...

Samsung Biologics says its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV).

Mounjaro sales were $7.4 billion in the quarter, up 110%. Zepbound sales were $4.3 billion, up 123%. Verzenio sales were $1.6 ...

Eisai Co. Ltd. and Shanghai Henlius Biotech Inc. have entered an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab in ...

The U.S. FDA has accepted and granted Priority Review for Pfizer’s supplemental Biologics License Application (sBLA) for HYMPAVZI.

4Q Loss: $1.6 billion (earnings were $411 million 4Q25) ...

ADARx Pharmaceuticals has named Donald Fong, MD, its new Chief Medical Officer (CMO). He served in the same post at BioCryst Pharmaceuticals.